Skip to content

13F-HR filed by TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 29 holding rows worth $497,219,000.

Accession
0001214659-22-002553
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 29 entries on the cover page, a total value of $497,219,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $497,219,000 with VALUE read as thousands by filing date, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ANAPTYSBIO INC032724106COM2,628,678$91,347,000thousands by filing date
HERON THERAPEUTICS INC427746102COM7,782,928$71,058,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM2,531,800$55,269,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 29,607,934$44,677,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM937,500$43,650,000thousands by filing date
CHEMOCENTRYX INC16383L106COM500,000$18,205,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM12,767,435$17,236,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW1,600,000$14,656,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM300,000$13,824,000thousands by filing date
ALLAKOS INC01671P100COM1,323,393$12,956,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK1,500,000$11,130,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW1,030,634$10,502,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM650,000$10,374,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM1,200,000$9,660,000thousands by filing date
LEGEND BIOTECH CORP52490G102SPONSORED ADS200,000$9,322,000thousands by filing date
ATYR PHARMA INC002120202COM NEW1,113,453$8,317,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM2,500,000$8,100,000thousands by filing date
CORVUS PHARMACEUTICALS INC221015100COM3,101,709$7,475,000thousands by filing date
BIOATLA INC09077B104COM297,914$5,848,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR20,000$5,419,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW763,888$5,286,000thousands by filing date
GENFIT S A372279109ADS1,055,994$5,280,000thousands by filing date
TANGO THERAPEUTICS INC87583X109COM468,750$5,128,000thousands by filing date
Reviva Pharmaceuticals Holdings Inc76152G100Common Stock1,200,000$3,468,000thousands by filing date
CALLIDITAS THERAPEUTICS AB SPONSERED13124Q106ADS100,000$2,476,000thousands by filing date
ASLAN PHARMACEUTICALS LTD04522R101ADR2,054,925$2,302,000thousands by filing date
EQUILLIUM INC29446K106COM600,000$2,262,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK59,122$1,332,000thousands by filing date
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK152,345$660,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-22-002553this filing2022-02-14acceptance time not in the bulk data set